Investigators have discovered the mechanisms underlying a T-cell receptor's immunosuppressive function, according to a study published Nature Immunology, findings that may provide insight into the development of novel precision therapeutics for chronic diseases, including cancer.
Researchers from Weill Cornell Medicine-Qatar (WCM-Q) have together with colleagues from the Weill Cornell Medicine campus in New York (WCM-NY) identified